Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy - current and future perspectives.

Prakoso, Darnel; Tate, Mitchel; Blasio, Miles J De; Ritchie, Rebecca H

Prakoso, Darnel; Tate, Mitchel; Blasio, Miles J De; Ritchie, Rebecca H.

Affiliation

Prakoso D; Departments of Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University Parkville Campus, Australia.
Tate M; Departments of Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University Parkville Campus, Australia.
Blasio MJ; Diabetes, Monash University, Clayton, Victoria 3800, Australia.
Ritchie RH; Departments of Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University Parkville Campus, Australia.

Clin Sci (Lond) ; 135(11): 1369-1387, 2021 06 11.

Article in En | MEDLINE | ID: mdl-34076247

Subject(s)

Diabetes Mellitus/genetics; Diabetic Cardiomyopathies/genetics; Genetic Therapy; Genetic Vectors/therapeutic use; Animals; Dependovirus/genetics; Diabetes Mellitus/therapy; Diabetic Cardiomyopathies/therapy; Gene Transfer Techniques; Genetic Therapy/methods; Humans

Key words

AAV; Diabetic Cadiomyopathy; Gene Therapy; diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Diabetes Mellitus / Diabetic Cardiomyopathies / Genetic Vectors Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Clin Sci (Lond) Year: 2021 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google